## Abstract ## __Background.__ To date, more than 60 gene expression profiling (GEP) studies have been published in the field of head and neck squamous cell carcinoma (HNSCC) with variable objectives, methods, and results. ## __Methods.__ The purpose of this study was to present a stateβofβtheβa
miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue
β Scribed by Latha Ramdas; Uma Giri; Cheryl L. Ashorn; Kevin R. Coombes; Adel El-Naggar; K. Kian Ang; Michael D. Story
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 584 KB
- Volume
- 31
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background.
The expression of miRNA in head and neck squamous cell carcinomas (HNSCCs) that had been classified as high risk by surgical pathologic features and validated by trial outcome for disease recurrence was determined and compared with matched adjacent normal tissues.
Methods.
miRNA and corresponding gene expression were determined using miRNA bioarrays and gene expression arrays.
Results.
Twenty miRNAs were determined to be differentially regulated in the HNSCC samples when compared with their normal tissue counterparts. Quantitative reverse transcriptaseβpolymerase chain reaction confirmed differential regulation of miRNA expression, and gene expression analysis on these sameβpaired samples confirmed the loss of putative mRNA targets including genes such as adenomatous polyposis coli, programmed cell death protein 4, and TGF beta receptor 3 in the tumor samples.
Conclusions.
These data suggest a role for the upregulation of specific miRNAs in highβrisk HNSCC. Furthermore, upregulation of these miRNAs may be responsible for the elimination of mRNAs that lead to the growth and progression of HNSCC. Β© 2009 Wiley Periodicals, Inc. Head Neck, 2009
π SIMILAR VOLUMES
## Abstract Inhibition of angiogenesis by blocking angiogenic cytokines or their pathways has become a major target in experimental cancer therapies. This therapeutical approach requires a profound knowledge of growth factor profiles that contribute to tumor growth and progression. The respective k
## Abstract ## Background Niban was initially identified in the Eker rat, a model of renal carcinogenesis. We examined Niban expression in head and neck squamous cell carcinoma (HNSCC) and head and neck dysplastic lesions. ## Methods Using a polyclonal rabbit antiβhuman Niban antibody, 43 cases
## Background: Squamous cell carcinoma (scc) of the head and neck region is rare in young patients and even less frequent in children 15 years or younger children. the patients reported in the literature are isolated cases and their management is always difficult because there is no large experienc
## Abstract ## Background The purpose of this study was to investigate the potential role of variable microRNA (miRNA) expression in the development of multidrug resistance (MDR) in head and neck cancer. ## Methods Head and neck squamous cell carcinoma cell lines UMSCCβ1 and SQ20B were treated w